GSK3b and dsRNA in CD8 cells
CD8 细胞中的 GSK3b 和 dsRNA
基本信息
- 批准号:10536526
- 负责人:
- 金额:$ 23.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:Autoimmune DiseasesCD8-Positive T-LymphocytesCellsDouble-Stranded RNAFailureGAG GeneGTP-Binding Protein alpha Subunits, GsHexachlorobenzeneHomeostasisImmune responseInfectionInnate Immune ResponseInterferonsMitochondriaMolecularPathway interactionsPatternPhosphorylationPlayProductionRegulationRoleSourceT cell responseT-LymphocyteTestingTranscriptVirusVirus Diseasescytokinenovelpathogenresponse
项目摘要
PROJECT SUMMARY
Double-stranded RNA (dsRNA) is a well-known pathogen-associated molecular pattern (PAMP)
generated during viral infections that triggers the innate immune response and plays a critical role in virus
protection through the direct effect on type I IFN. However, in recent years it has been clear that this pathway
can also be induced by endogenous dsRNA, with mitochondria transcripts being one of the major sources of
endogenous dsRNA. The presence of endogenous dsRNA suggests that there must be mechanisms in place to
keep on check their accumulation to avoid triggering RLRs pathways. Although there is a number of studies on
how the production of type I IFN resulting from endogenous dsRNA can indirectly modulate T cell response, no
previous studies have examined dsRNA in T cells. Our recent studies have revealed the presence of endogenous
dsRNA in CD8 cells upon activation, and mitochondria seems to be the primary source. In addition, we identify
a new mechanism that CD8 cells use to restrict the levels of dsRNA generated: inactivation of mitochondria
GSK3 by phosphorylation on Ser389. Interestingly, failure to inactivate GSK3 by phospho-Ser389 results in a
greater accumulation of mitochondrial dsRNA in activated CD8 cells. Importantly, we also found that failure to
inactivate GSK3 by phospho-Ser389 results in higher levels of IFN produced by CD8 cells. We hypothesize that
mitochondrial dsRNAs are generated during activation of CD8 cells, can trigger the RLR pathway and contribute
to sustain IFN production. We also propose that mitochondrial GSK3 interferes with the mitochondrial
degradosome and that inactivation of mitochondrial GSK3 through phosphorylation on Ser389 in response to
dsRNA is essential for maintaining dsRNA-homeostasis and restricting IFN production. We will test this
hypothesis with the following specific aims: 1) to show that mitochondrial dsRNA is generated during activation
of CD8 cells and contributes to the production of IFN. 2) to show that inactivation of GSK3 through Ser389-
phosphorylation plays a role in the homeostasis of mitochondrial dsRNA during activation of CD8 cells. The
results from the proposed studies could be a major breakthrough since they will show how endogenous dsRNA
can contribute to sustain cytokine production in activated CD8 cells, and its potential impact on autoimmune
disease.
项目摘要
双链RNA(DSRNA)是一种众所周知的病原体相关分子模式(PAMP)
在病毒感染过程中产生的,触发先天免疫反应并在病毒中起关键作用
通过直接对I型IFN的影响进行保护。但是,近年来很明显这条途径
也可以由内源性dsRNA诱导,线粒体转录本是主要来源之一
内源性dsRNA。内源性dsRNA的存在表明必须有机制
继续检查其积累,以避免触发RLRS路径。尽管有许多研究
内源性DSRNA产生的I型IFN的产生如何间接调节T细胞反应,否
先前的研究检查了T细胞中的DSRNA。我们最近的研究揭示了内源性的存在
激活后CD8细胞中的dsRNA,线粒体似乎是主要来源。此外,我们确定
CD8细胞用来限制DSRNA水平的新机制:线粒体失活
Ser389上的磷酸化GSK3。有趣的是,磷酸-Ser389未能使GSK3失活导致
线粒体DSRNA在活化的CD8细胞中的积累越来越大。重要的是,我们还发现
磷酸 - 塞尔389的灭活GSK3会导致CD8细胞产生的较高水平的IFN。我们假设这一点
线粒体DSRNA是在CD8细胞激活期间产生的,可以触发RLR途径并贡献
维持IFN生产。我们还建议线粒体GSK3会干扰线粒体
通过Ser389上的磷酸化对线粒体GSK3的降解体和线粒体的灭活,以响应
dsRNA对于维持dsRNA常肠症和限制IFN产生至关重要。我们将测试这个
以下特定目的的假设:1)表明在激活过程中产生线粒体dsRNA
CD8细胞的产生,有助于产生IFN。 2)表明GSK3通过Ser389-灭活
在CD8细胞激活过程中,磷酸化在线粒体DSRNA的体内稳态中起作用。这
拟议研究的结果可能是一个重大突破,因为它们将显示内源性dsRNA如何
可以有助于维持活化的CD8细胞中的细胞因子产生及其对自身免疫的潜在影响
疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mercedes Rincon其他文献
Mercedes Rincon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mercedes Rincon', 18)}}的其他基金
Enhancing mitochondrial metabolism to improve anti-tumor CD8 immune response
增强线粒体代谢,提高抗肿瘤CD8免疫反应
- 批准号:
10578743 - 财政年份:2022
- 资助金额:
$ 23.33万 - 项目类别:
Targeting mitochondrial regulator MCJ to enhance CD8 cell immune response
靶向线粒体调节剂 MCJ 增强 CD8 细胞免疫反应
- 批准号:
10293952 - 财政年份:2020
- 资助金额:
$ 23.33万 - 项目类别:
Fine-tuning of mitochondrial Complex I activity in CD8 cells
CD8 细胞中线粒体复合物 I 活性的微调
- 批准号:
10092947 - 财政年份:2020
- 资助金额:
$ 23.33万 - 项目类别:
Fostering entrepreneurship in biomedical research
培养生物医学研究创业精神
- 批准号:
8998210 - 财政年份:2016
- 资助金额:
$ 23.33万 - 项目类别:
IL-6: an innate immune regulator for the plasticity of Tfh cells
IL-6:Tfh 细胞可塑性的先天免疫调节剂
- 批准号:
8434542 - 财政年份:2012
- 资助金额:
$ 23.33万 - 项目类别:
COBRE: UVT: CORE TRANSGENIC ANIMAL PROGRAM: MOUSE GENOMIC DNA BAC LIBRARY
COBRE:UVT:核心转基因动物计划:小鼠基因组 DNA BAC 文库
- 批准号:
7959621 - 财政年份:2009
- 资助金额:
$ 23.33万 - 项目类别:
MCJ function in mouse mammary tumor properties
MCJ 在小鼠乳腺肿瘤特性中的功能
- 批准号:
7807612 - 财政年份:2008
- 资助金额:
$ 23.33万 - 项目类别:
COBRE: UVT: CORE TRANSGENIC ANIMAL PROGRAM: MOUSE GENOMIC DNA BAC LIBRARY
COBRE:UVT:核心转基因动物计划:小鼠基因组 DNA BAC 文库
- 批准号:
7720875 - 财政年份:2008
- 资助金额:
$ 23.33万 - 项目类别:
MCJ function in mouse mammary tumor properties
MCJ 在小鼠乳腺肿瘤特性中的功能
- 批准号:
7390544 - 财政年份:2008
- 资助金额:
$ 23.33万 - 项目类别:
相似国自然基金
肺部IFN-γ通过上调CXC趋化因子募集Th1与CD8阳性T淋巴细胞的作用及机制研究
- 批准号:81970013
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Engineered TCR-Treg Cell Therapies Targeting Type 1 Diabetes Autoantigens
针对 1 型糖尿病自身抗原的工程化 TCR-Treg 细胞疗法
- 批准号:
10764143 - 财政年份:2023
- 资助金额:
$ 23.33万 - 项目类别:
Mechanisms by which PIM kinase modulates the effector function of autoreactive CD8 T cells in type 1 diabetes
PIM 激酶调节 1 型糖尿病自身反应性 CD8 T 细胞效应功能的机制
- 批准号:
10605431 - 财政年份:2023
- 资助金额:
$ 23.33万 - 项目类别:
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 23.33万 - 项目类别:
Unmasking the Immunomodulatory Roles of CD7 Signaling
揭示 CD7 信号传导的免疫调节作用
- 批准号:
10637876 - 财政年份:2023
- 资助金额:
$ 23.33万 - 项目类别: